Published in J Neural Transm (Vienna) on September 22, 2013
Sleep apnea and the subsequent risk of Parkinson's disease: a 3-year nationwide population-based study. Neuropsychiatr Dis Treat (2017) 1.36
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry (2015) 0.78
Parkinson's disease research in a prospective cohort in China. Parkinsonism Relat Disord (2015) 0.77
Variations in Incidence and Prevalence of Parkinson's Disease in Taiwan: A Population-Based Nationwide Study. Parkinsons Dis (2016) 0.77
The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease. Transl Neurodegener (2016) 0.77
Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson's Disease: Considerations from a Pilot Study. J Parkinsons Dis (2015) 0.75
Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using (18)F-fallypride micro-positron emission tomography scanning. Exp Ther Med (2015) 0.75
Clinical profile of Parkinson's disease in the Gumei community of Minhang district, Shanghai. Clinics (Sao Paulo) (2014) 0.75
Development, reliability and validity of the psychosocial adaptation scale for Parkinson's disease in Chinese population. Int J Clin Exp Med (2015) 0.75
Systematic analysis of microarray datasets to identify Parkinson's disease‑associated pathways and genes. Mol Med Rep (2017) 0.75
Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C/G polymorphism and the risk of sporadic Parkinson's diseases: a meta-analysis. Neurol Sci (2014) 0.75
Physiotherapy in Parkinson's Disease: Building ParkinsonNet in Czechia. Parkinsons Dis (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology (2006) 6.86
Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol (2006) 5.40
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol (2003) 5.00
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol (2002) 3.87
Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci (1999) 3.57
Age-related changes in oxidized proteins. J Biol Chem (1987) 3.18
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol (2009) 3.02
Does oxidative damage to DNA increase with age? Proc Natl Acad Sci U S A (2001) 2.91
Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol (2007) 2.71
Systematic review of incidence studies of Parkinson's disease. Mov Disord (2003) 2.49
Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry (2004) 2.47
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci (2007) 2.39
Aetiology of Parkinson's disease. Lancet (1984) 2.32
Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol (2005) 1.88
Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet (2005) 1.75
Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord (2003) 1.66
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord (2008) 1.61
Female preponderance of Parkinson's disease in Japan. Neuroepidemiology (2002) 1.60
Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology (2009) 1.48
Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid Redox Signal (2005) 1.47
Exploring gene-environment interactions in Parkinson's disease. Hum Genet (2008) 1.43
Validity of family history data on PD: evidence for a family information bias. Neurology (2003) 1.41
Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.40
The pathogenesis of cell death in Parkinson's disease. Neurology (2006) 1.38
Epidemiologic study of Parkinson's disease in Hong Kong. Neurology (1989) 1.21
Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology (1996) 1.19
A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol (1985) 1.16
A systematic review of the worldwide prevalence and incidence of Parkinson's disease. J Med Assoc Thai (2011) 1.16
Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology (2001) 1.14
A review of the health-related quality of life and economic impact of Parkinson's disease. Drugs Aging (2006) 1.12
A population perspective on diagnostic criteria for Parkinson's disease. Neurology (1997) 1.08
Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies. Mov Disord (2006) 1.08
Caregiver strain in Parkinson's disease and the impact of disease duration. Eur J Phys Rehabil Med (2008) 1.05
Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China. Mov Disord (2003) 1.04
Complete ascertainment of Parkinson disease in the Swedish Twin Registry. Neurobiol Aging (2007) 1.02
Prevalence of Parkinson's disease in populations of African ancestry: a review. J Natl Med Assoc (2004) 1.02
Direct medical costs associated with Parkinson's disease: a population-based study. Mov Disord (2006) 0.97
Costs of Parkinson's disease in eastern Europe: a Czech cohort study. Parkinsonism Relat Disord (2009) 0.97
Incidence of Parkinson disease in Wakayama, Japan. J Epidemiol (2002) 0.92
Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA. Chin Med J (Engl) (1991) 0.90
Pathogenesis of Parkinson's disease. Baillieres Clin Neurol (1997) 0.89
Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction. Metabolism (2008) 0.88
A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen. Arch Neurol (1996) 0.88
Incidence of Parkinson's disease in Singapore. Parkinsonism Relat Disord (2006) 0.87
Economic and health-related quality of life considerations of new therapies in Parkinson's disease. Pharmacoeconomics (2001) 0.86
[A cross-sectional study of neurological disease in the veterans of military communities in Beijing]. Zhonghua Nei Ke Za Zhi (2010) 0.86
Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology (2009) 0.85
Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians. Neurology (2004) 0.84
Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol (1996) 0.84
Prevalence of Parkinson's disease in a Chinese population. Acta Neurol Scand (2004) 0.84
The prevalence of PD in a nutritionally deficient rural population in China. Acta Neurol Scand (2005) 0.83
Prevalence of Parkinson's disease in Korea. J Clin Neurosci (2007) 0.81
Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century. Neuroepidemiology (2009) 0.79
Case ascertainment uncertainties in prevalence surveys of Parkinson's disease. Mov Disord (1998) 0.79
Parkinson's disease: aetiology, diagnosis, and management. Hong Kong Med J (2005) 0.79
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res (2008) 5.05
Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet (2013) 3.90
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49
Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem (2002) 3.37
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol (2004) 2.93
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol (2007) 2.52
CtIP links DNA double-strand break sensing to resection. Mol Cell (2009) 2.11
Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis (2010) 2.05
Biocompatible copper(I) catalysts for in vivo imaging of glycans. J Am Chem Soc (2010) 1.98
VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. J Clin Oncol (2008) 1.94
Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res (2004) 1.91
Heme oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med (2009) 1.87
Metal ions and flexibility in a viral RNA pseudoknot at atomic resolution. Proc Natl Acad Sci U S A (2002) 1.82
Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians. Crit Care Med (2007) 1.71
Increasing the efficacy of bioorthogonal click reactions for bioconjugation: a comparative study. Angew Chem Int Ed Engl (2011) 1.66
BCL2 genetic variants are associated with acute kidney injury in septic shock*. Crit Care Med (2012) 1.61
Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat (2009) 1.56
Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev (2002) 1.54
Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ Health Perspect (2005) 1.54
Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum. Clin Infect Dis (2006) 1.54
Paced QRS duration as a predictor for clinical heart failure events during right ventricular apical pacing in patients with idiopathic complete atrioventricular block: results from an observational cohort study (PREDICT-HF). Eur J Heart Fail (2012) 1.54
Metabolic labeling of sialic acids in living animals with alkynyl sugars. Angew Chem Int Ed Engl (2009) 1.53
Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. Mol Biol Rep (2014) 1.53
Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1. Am J Clin Nutr (2006) 1.53
Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol (2009) 1.52
Chemoenzymatic synthesis of GDP-L-fucose and the Lewis X glycan derivatives. Proc Natl Acad Sci U S A (2009) 1.51
Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol (2013) 1.47
Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis (2010) 1.47
Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res (2002) 1.45
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol (2008) 1.42
Characterization and thermodynamic properties of quadruplex/duplex competition. FEBS Lett (2002) 1.40
Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis (2014) 1.40
Site-specific chemical protein conjugation using genetically encoded aldehyde tags. Nat Protoc (2012) 1.40
Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo. Cell Stem Cell (2013) 1.40
Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.38
Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness. Crit Care Med (2015) 1.38
Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation. Infect Immun (2006) 1.37
Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res (2005) 1.36
Biodistribution and biopersistence of ceria engineered nanomaterials: size dependence. Nanomedicine (2012) 1.34
Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res (2002) 1.33
Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.33
Trends in prevalence, awareness, treatment, and control of diabetes mellitus in mainland china from 1979 to 2012. Int J Endocrinol (2013) 1.32
Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells. J Am Chem Soc (2009) 1.31
Array feature size influences nucleic acid surface capture in DNA microarrays. Proc Natl Acad Sci U S A (2007) 1.31
Poultry market closures and human infection with influenza A(H7N9) virus, China, 2013-14. Emerg Infect Dis (2014) 1.29
Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect (2006) 1.28
A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res (2008) 1.27
Metabolic labeling of fucosylated glycans in developing zebrafish. ACS Chem Biol (2011) 1.25
XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis (2007) 1.25
Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control (2008) 1.25
In-home solid fuel use and cardiovascular disease: a cross-sectional analysis of the Shanghai Putuo study. Environ Health (2012) 1.24
Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clin Cancer Res (2008) 1.24
The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS One (2011) 1.23
Rapid and selective detection of fatty acylated proteins using omega-alkynyl-fatty acids and click chemistry. J Lipid Res (2009) 1.20
Second hand smoke, age of exposure and lung cancer risk. Lung Cancer (2008) 1.19
Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol (2003) 1.18
miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition. J Natl Cancer Inst (2013) 1.18
Human exposure to live poultry and psychological and behavioral responses to influenza A(H7N9), China. Emerg Infect Dis (2014) 1.17
Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis (2008) 1.15
T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum. Infect Immun (2006) 1.15
MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol (2010) 1.14
Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers. Cancer Res (2009) 1.13
One-pot copper(I)-catalyzed synthesis of 3,5-disubstituted isoxazoles. J Org Chem (2005) 1.13
Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods (2010) 1.13
Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei. PLoS Negl Trop Dis (2010) 1.12
MDM2 polymorphism, survival, and histology in early-stage non-small-cell lung cancer. J Clin Oncol (2007) 1.12
A Large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis (2010) 1.12
Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. Int J Cancer (2008) 1.11
Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control (2004) 1.11
Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma. Mod Pathol (2007) 1.10
Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev (2006) 1.10
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes. Pharmacogenet Genomics (2009) 1.09
Sulfated ligands for the copper(I)-catalyzed azide-alkyne cycloaddition. Chem Asian J (2011) 1.09
Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells. Carcinogenesis (2008) 1.08
Nutritional status improves after treatment of schistosoma japonicum-infected children and adolescents. J Nutr (2006) 1.08
Targeted metabolic labeling of yeast N-glycans with unnatural sugars. Proc Natl Acad Sci U S A (2010) 1.08
Identification of the major functional proteins of prokaryotic lipid droplets. J Lipid Res (2011) 1.07
A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol (2008) 1.07
Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection. Am J Trop Med Hyg (2006) 1.07
Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.06
Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Carcinogenesis (2009) 1.06
Toenail arsenic concentrations, GSTT1 gene polymorphisms, and arsenic exposure from drinking water. Cancer Epidemiol Biomarkers Prev (2005) 1.06
Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res (2012) 1.05
Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer. Proc Natl Acad Sci U S A (2011) 1.05
Rap1 signal controls B cell receptor repertoire and generation of self-reactive B1a cells. Immunity (2006) 1.03
Cross-shift airway responses and long-term decline in FEV1 in cotton textile workers. Am J Respir Crit Care Med (2007) 1.03
Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis. Am J Chin Med (2008) 1.03
Proteomic analysis of mitochondria from Caenorhabditis elegans. Proteomics (2009) 1.02
Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS One (2013) 1.02
Chemically immobilized T4-bacteriophage for specific Escherichia coli detection using surface plasmon resonance. Analyst (2010) 1.02
Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study. Circ Arrhythm Electrophysiol (2014) 1.02
Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis (2008) 1.01
Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol (2009) 1.01
Tracking N-acetyllactosamine on cell-surface glycans in vivo. Angew Chem Int Ed Engl (2011) 1.01
MDM2 promoter polymorphism and pancreatic cancer risk and prognosis. Clin Cancer Res (2008) 1.01